Abstract
Red-light-responsive supramolecular valves constructed by tetra-ortho-methoxy-substituted azobenzene (mAzo) and β-cyclodextrin (β-CD) were used to control drug release from mesoporous silica nanoparticles (MSNs). Doxorubicin (DOX) was used as a model drug and loaded into nanopores of mAzo modified MSNs. β-CD formed supramolecular valves with mAzo by host-guest interaction and closed the nanopores. Red light was able to open the supramolecular valves and induce DOX release even in deep tissue.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Azo Compounds / chemistry*
-
Delayed-Action Preparations / chemistry*
-
Doxorubicin / chemistry*
-
Drug Compounding
-
Drug Liberation
-
Hydrogen-Ion Concentration
-
Light
-
Nanoparticles / chemistry*
-
Nanoparticles / ultrastructure
-
Nanopores / ultrastructure
-
Porosity
-
Silicon Dioxide / chemistry
-
beta-Cyclodextrins / chemistry*
Substances
-
Azo Compounds
-
Delayed-Action Preparations
-
beta-Cyclodextrins
-
Silicon Dioxide
-
Doxorubicin
-
azobenzene
-
betadex